Cancer

CZI, State and City Leaders Launch Chan Zuckerberg Biohub New York

CZ Biohub New York is catalyzing collaboration among scientists in the New York area from Columbia University, The Rockefeller University,…

1 year ago

Proteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten® Test

CAMBRIDGE, United Kingdom, Oct. 9, 2024 /PRNewswire/ -- Proteotype Diagnostics Ltd, in collaboration with the University of Southampton, has been awarded…

1 year ago

Guardian launches GuardianWell™, a new digital hub designed to enhance benefits utilization and inspire well-being®

With half of employers looking to improve workforce understanding of benefits, GuardianWell will enhance benefits utilization by offering relevant wellness…

1 year ago

BuzzRx® Unveils Insights From New “State of Our Health” Data Report

In-Depth Exploration of Five Key Topics for October's Awareness Month Themes FORT LAUDERDALE, Fla., Oct. 9, 2024 /PRNewswire/ -- BuzzRx,…

1 year ago

Verseon Develops Superior Approach in Combining AI Models for Greater Accuracy

Peer-reviewed paper describes novel ensembling technique that offers 150% improvement over current state of the art FREMONT, Calif., Oct. 9,…

1 year ago

Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors

– Data show that p300 KAT inhibitor KB-9558 was highly selective against human papillomavirus (HPV) oncoproteins E6 and E7, and…

1 year ago

Aprea Therapeutics Engages Philippe Pultar, MD to Serve as Senior Medical Advisor and Lead WEE1 Clinical Development

DOYLESTOWN, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical…

1 year ago

Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials

Data from three separate clinical trials documents the strong ability of the AI-Immunology™ platform to select clinically relevant vaccine targets…

1 year ago